KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Equity Ratio (2018 - 2025)

Historic Equity Ratio for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to 0.26.

  • ClearPoint Neuro's Equity Ratio fell 6355.01% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year decrease of 6355.01%. This contributed to the annual value of 0.65 for FY2024, which is 3053.59% up from last year.
  • Latest data reveals that ClearPoint Neuro reported Equity Ratio of 0.26 as of Q3 2025, which was down 6355.01% from 0.31 recorded in Q2 2025.
  • ClearPoint Neuro's 5-year Equity Ratio high stood at 0.74 for Q4 2021, and its period low was 0.26 during Q3 2025.
  • Over the past 5 years, ClearPoint Neuro's median Equity Ratio value was 0.65 (recorded in 2023), while the average stood at 0.61.
  • Per our database at Business Quant, ClearPoint Neuro's Equity Ratio surged by 104079.11% in 2021 and then tumbled by 6355.01% in 2025.
  • ClearPoint Neuro's Equity Ratio (Quarter) stood at 0.74 in 2021, then fell by 10.64% to 0.66 in 2022, then decreased by 25.34% to 0.5 in 2023, then surged by 30.54% to 0.65 in 2024, then plummeted by 59.4% to 0.26 in 2025.
  • Its Equity Ratio stands at 0.26 for Q3 2025, versus 0.31 for Q2 2025 and 0.66 for Q1 2025.